尿路基因制药 URGN
$24.75 −$0.98 (-3.81%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $24.00 -3.03%
开盘$25.83
昨收$25.73
当日区间$24.40 – $26.34
成交量1.76M
市值$1.21B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$72.46M+199.2% YoY
营业利润$111,000.00+100.3% YoY
净利润-$14.35M+71.3% YoY
摊薄每股收益-$0.28+73.3% YoY
自由现金流-$33.07M+17.3% YoY
经营现金流-$33.01M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率90.8%
营业利润率-35.3%
净利率-51.7%
资产收益率-42.3%
流动比率3.80
负债/资产比率152.4%
现金及投资$107.98M
总负债$194.03M
净现金（净负债）-$86.06M
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $72.46M | $50.96M | $109.79M | $37.84M | $27.48M |
| 营业总收入 | $72.46M | $50.96M | $109.79M | $37.84M | $27.48M |
| 营业成本 | $6.57M | $4.14M | $12.45M | $3.29M | $3.28M |
| 毛利润 | $65.88M | $46.82M | $97.34M | $34.55M | $24.20M |
| 营业费用 | $65.77M | $67.08M | $222.20M | $53.66M | $51.59M |
| 销售及管理费用 | $48.44M | $51.49M | $155.10M | $39.35M | $37.58M |
| 研发费用 | $17.34M | $15.60M | $67.11M | $14.31M | $14.01M |
| 营业利润 | $111,000.00 | -$20.26M | -$124.86M | -$19.12M | -$27.39M |
| 非经营性利息净收入（支出） | -$8.49M | -$7.76M | -$27.88M | -$7.52M | -$6.82M |
| 非经营性利息收入 | $946,000.00 | $931,000.00 | $5.97M | $908,000.00 | $1.18M |
| 非经营性利息支出 | $4.89M | $4.19M | $15.35M | $3.77M | $3.37M |
| 其他财务成本合计 | $4.55M | $4.51M | $18.50M | $4.66M | $4.62M |
| 其他收入（支出） | -$347,000.00 | -$323,000.00 | -$670,000.00 | -$5,000.00 | -$197,000.00 |
| 其他非经营性收入（支出） | -$347,000.00 | -$323,000.00 | -$670,000.00 | -$5,000.00 | -$197,000.00 |
| 税前利润 | -$8.72M | -$28.35M | -$153.42M | -$26.64M | -$34.40M |
| 税费 | $5.63M | -$4.77M | $78,000.00 | -$275,000.00 | -$1.05M |
| 净利润 | -$14.35M | -$23.57M | -$153.49M | -$26.36M | -$33.35M |
| 持续经营利润 | -$14.35M | -$23.57M | -$153.49M | -$26.36M | -$33.35M |
| 归属母公司净利润 | -$14.35M | -$23.57M | -$153.49M | -$26.36M | -$33.35M |
| 归属普通股股东净利润 | -$14.35M | -$23.57M | -$153.49M | -$26.36M | -$33.35M |
| 基本每股收益 | -$0.28 | -$0.47 | -$3.19 | -$0.54 | -$0.69 |
| 摊薄每股收益 | -$0.28 | -$0.47 | -$3.19 | -$0.54 | -$0.69 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $252.59M | $253.69M | $200.46M | $200.46M | $185.05M |
| 流动资产合计 | $235.43M | $237.46M | $186.02M | $186.02M | $168.55M |
| 现金及现金等价物与短期投资 | $107.98M | $140.27M | $120.46M | $120.46M | $127.03M |
| -现金及现金等价物 | $79.13M | $109.97M | $110.75M | $110.75M | $90.04M |
| -短期投资 | $28.84M | $30.31M | $9.71M | $9.71M | $36.99M |
| 应收款 | $88.76M | $55.41M | $33.08M | $33.08M | $19.70M |
| -应收账款 | $88.76M | $55.41M | $33.08M | $33.08M | $19.70M |
| 存货 | $24.59M | $20.92M | $16.46M | $16.46M | $8.34M |
| 受限现金 | $1.33M | $1.33M | $1.35M | $1.35M | $1.35M |
| 其他流动资产 | $12.78M | $19.53M | $14.67M | $14.67M | $12.12M |
| 非流动资产合计 | $17.16M | $16.23M | $14.43M | $14.43M | $16.50M |
| 固定资产净值 | $8.23M | $8.56M | $9.09M | $9.09M | $9.18M |
| -固定资产原值 | $12.97M | $13.22M | $13.68M | $13.68M | $13.70M |
| -累计折旧 | -$4.74M | -$4.66M | -$4.59M | -$4.59M | -$4.51M |
| 其他非流动资产 | $8.94M | $7.67M | $5.34M | $5.34M | $6.94M |
| 负债合计 | $384.99M | $377.94M | $305.93M | $305.93M | $300.45M |
| 流动负债合计 | $61.92M | $50.64M | $46.42M | $46.42M | $42.24M |
| 应付款 | $15.47M | $17.21M | $12.14M | $12.14M | $10.28M |
| -应付账款 | $15.47M | $17.21M | $12.14M | $12.14M | $10.28M |
| 一年内应计费用 | $24.47M | $18.14M | $15.58M | $15.58M | $15.89M |
| 短期债务及融资租赁负债 | $2.10M | – | – | – | – |
| -一年内到期融资租赁负债 | $2.10M | – | – | – | – |
| 其他流动负债 | $7.62M | $5.45M | $5.19M | $5.19M | $4.96M |
| 非流动负债合计 | $323.07M | $327.31M | $259.51M | $259.51M | $258.21M |
| 长期应付账款及其他应付款 | $3.90M | $3.90M | $3.90M | $3.90M | $3.79M |
| 长期债务及融资租赁负债 | $194.03M | $195.18M | $128.33M | $128.33M | $128.35M |
| -长期债务 | $188.73M | $189.53M | $122.21M | $122.21M | $122.11M |
| -长期融资租赁负债 | $5.30M | $5.65M | $6.12M | $6.12M | $6.24M |
| 衍生产品负债 | $125.14M | $128.23M | $127.28M | $127.28M | $126.07M |
| 股东权益合计 | -$132.40M | -$124.25M | -$105.47M | -$105.47M | -$115.41M |
| 股东权益 | -$132.40M | -$124.25M | -$105.47M | -$105.47M | -$115.41M |
| 股本 | $135,000.00 | $134,000.00 | $133,000.00 | $133,000.00 | $128,000.00 |
| -普通股 | $135,000.00 | $134,000.00 | $133,000.00 | $133,000.00 | $128,000.00 |
| 资本公积 | $865.11M | $858.90M | $854.09M | $854.09M | $817.79M |
| 留存收益 | -$997.64M | -$983.29M | -$959.72M | -$959.72M | -$933.35M |
| 不影响留存收益的损益 | -$2,000.00 | $8,000.00 | $19,000.00 | $19,000.00 | $23,000.00 |
| 投资及预付款 | – | – | $0.00 | $0.00 | $380,000.00 |
| -可供出售证券 | – | – | – | – | $380,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$33.01M | -$45.32M | -$162.44M | -$38.33M | -$42.27M |
| 持续经营经营活动现金流净额 | -$33.01M | -$45.32M | -$162.44M | -$38.33M | -$42.27M |
| 持续经营净利润 | -$14.35M | -$23.57M | -$153.49M | -$26.36M | -$33.35M |
| 持续经营损益 | $991,000.00 | $1.06M | $2.87M | $1.27M | $1.47M |
| 折旧、折耗与摊销 | $668,000.00 | $652,000.00 | $2.41M | $679,000.00 | $639,000.00 |
| 其他非现金项目 | -$796,000.00 | $1.97M | $3.60M | $99,000.00 | -$397,000.00 |
| 营运资金变动 | -$24.57M | -$30.08M | -$27.91M | -$17.06M | -$13.50M |
| -应收款变动 | -$33.35M | -$22.33M | -$12.78M | -$13.38M | -$54,000.00 |
| -存货变动 | -$3.67M | -$4.46M | -$7.24M | -$8.12M | -$1.21M |
| -预付资产变动 | $6.75M | -$4.86M | -$5.83M | -$2.55M | -$67,000.00 |
| -应付账款及应计费用变动 | $7.02M | $3.95M | $3.23M | $3.95M | -$5.32M |
| -其他流动资产变动 | -$1.27M | -$2.33M | -$4.57M | $1.60M | -$5.96M |
| -其他流动负债变动 | -$60,000.00 | -$53,000.00 | -$729,000.00 | $1.44M | -$891,000.00 |
| 投资活动现金流净额 | $1.67M | -$20.69M | $61.56M | $27.72M | $31.40M |
| 持续经营投资活动现金流净额 | $1.67M | -$20.69M | $61.56M | $27.72M | $31.40M |
| 固定资产购置及出售净额 | -$60,000.00 | -$54,000.00 | -$289,000.00 | -$17,000.00 | -$87,000.00 |
| 投资购置及出售净额 | $1.73M | -$20.63M | $61.85M | $27.73M | $31.49M |
| 筹资活动现金流 | $500,000.00 | $65.20M | $39.92M | $31.32M | $8.27M |
| 持续经营筹资活动现金流净额 | $500,000.00 | $65.20M | $39.92M | $31.32M | $8.27M |
| 债务发行及偿还净额 | -$387,000.00 | $65.03M | -$1.86M | -$1.86M | $0.00 |
| 股票期权行使所得 | $887,000.00 | $179,000.00 | $1.97M | $1.34M | $302,000.00 |
| 期末现金余额 | $80.46M | $111.30M | $112.10M | $112.10M | $91.39M |
| 现金净变动 | -$30.83M | -$800,000.00 | -$60.97M | $20.71M | -$2.60M |
| 期初现金余额 | $111.30M | $112.10M | $173.06M | $91.39M | $93.99M |
| 自由现金流 | -$33.07M | -$45.37M | -$162.73M | -$38.34M | -$42.36M |
| 普通股发行净额 | – | $0.00 | $39.80M | $31.83M | – |
| -其他营运资金变动 | – | – | -$1,000.00 | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 URGN。
登录后参与讨论。